Genomic health, inc (GHDX)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues:
Total revenues

394,111

340,750

327,868

287,458

275,706

261,595

235,173

206,111

178,101

149,548

Operating expenses:
Cost of product revenues

64,326

54,718

58,828

55,135

48,742

42,100

37,018

33,832

34,634

32,562

Research and development

64,200

62,811

60,158

58,445

53,076

64,177

49,104

39,864

33,225

35,691

Selling and marketing

164,779

157,001

151,042

143,557

137,846

112,758

93,553

83,613

71,405

61,132

General and administrative

76,910

72,670

73,272

64,348

59,669

54,392

47,064

40,543

34,913

29,564

Total operating expenses

370,215

347,200

343,300

321,485

299,333

273,427

226,739

197,852

174,177

158,949

Income from operations

23,896

-6,450

-15,432

-34,027

-23,627

-11,832

8,434

8,259

3,924

-9,401

Impairment of investments

-

-

-

-

-

643

-

-

-

-

Interest income

-

-

-

-

192

222

295

221

232

612

Interest income

2,385

934

418

221

-

-

-

-

-

-

Unrealized (loss) gain on equity securities

875

7

-

-

-

-

-

-

-

-

Gain on sale of equity securities

-

2,807

3,208

-

0

-

-

-

-

-

Other (expense) income, net

-232

349

-732

-498

-764

-158

-58

-205

-4

-62

Income before income taxes

26,924

-2,353

-12,538

-34,304

-24,199

-12,411

8,671

8,275

4,152

-8,851

Income tax expense

1,247

1,504

1,381

-996

393

346

422

429

-136

560

Net income

25,677

-3,857

-13,919

-33,308

-24,592

-12,757

8,249

7,846

4,288

-9,411

Basic and diluted net loss per share (in dollars per share)

-

-

-

-1.03

-0.78

-0.42

-

-

-

-

Shares used in computing basic and diluted net loss per share (in shares)

-

-

-

32,382

31,453

30,512

-

-

-

-

Basic net income per share (in dollars per share)

0.72

-0.11

-0.42

-

-

-

0.27

0.27

0.15

-0.33

Diluted net income per share (in dollars per share)

0.68

-0.11

-0.42

-

-

-

0.26

0.26

0.14

-0.33

Shares used in computing basic net income per share (in shares)

35,727

34,495

33,264

-

-

-

30,326

29,395

28,815

28,563

Shares used in computing diluted net income per share (in shares)

37,555

34,495

33,264

-

-

-

32,152

30,754

29,653

28,563

Product
Total revenues

394,111

340,451

326,918

287,458

275,706

259,192

233,457

204,766

174,870

146,581

Contract
Total revenues

-

299

950

-

-

2,403

1,716

1,345

3,231

2,967